Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion

Am J Hematol. 2010 Feb;85(2):146. doi: 10.1002/ajh.21597.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Diagnosis, Differential
  • Disseminated Intravascular Coagulation / blood
  • Disseminated Intravascular Coagulation / chemically induced
  • Disseminated Intravascular Coagulation / diagnosis*
  • Disseminated Intravascular Coagulation / therapy
  • Fibrinolysis / drug effects*
  • Humans
  • Lymphocytosis / blood
  • Lymphocytosis / diagnosis
  • Lymphocytosis / drug therapy
  • Male
  • Rituximab
  • Severity of Illness Index
  • Thrombocytopenia / blood
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / diagnosis*
  • Thrombocytopenia / therapy
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab